Perspectives of heart-type fatty acid binding protein application in diagnostics of myocardial infarction

Close metadata

Recommended articles:

Predictors and impact of myocardial injury (VARC-3 criteria) after transcatheter aortic valve implantation. Russian Journal of Cardiology and Cardiovascular Surgery. 2024;(5):489-498

Advantages of long-term telemetric electrocardiogram monitoring in patients with myocardial infarction. Russian Cardiology Bulletin. 2024;(2):39-46

Patients with ischaemic heart disease and non-steroidal anti-inflammatory drugs dosing — recommendations and real-life clinical setting. Russian Journal of Preventive Medicine. 2024;(6):68-73

The role of FABP4 in the development of fetal growth retardation in women with gestational diabetes mellitus and threatened late miscarriage diagnosed in the second trimester of pregnancy. Russian Journal of Human Reproduction. 2024;(3):50-56

The relationship between the specialized hospitals and departments medical doctors provision with myocardial infraction and cerebral stroke lethality. Russian Journal of Preventive Medicine. 2024;(7):30-37

Alveolar adenoma of the lung. Russian Journal of Archive of Pathology. 2024;(4):38-41

Perioperative troponin monitoring in non-cardiac surgery. Russian Journal of Anesthesiology and Reanimatology. 2024;(4):59-65

In-hospital therapy for myocardial infarction in the Russian Federation according to the REGION-IM registry: compliance with clinical guidelines. Russian Cardiology Bulletin. 2024;(3):81-91

Sympathetic innervation of the left ventricle in patients with myocardial infarction in acute and long-term period. Russian Cardiology Bulletin. 2024;(3):92-97

Issues of morphological diagnosis and pathogenesis of tuberculosis. Russian Journal of Archive of Pathology. 2024;(5):81-93

Keywords:

myocardial infarction

fatty acid binding protein

differential diagnostics

troponin

biochemical markers

Authors:

Kalinichenko R.M.

Pervyĭ MGMU im. I.M. Sechenova, kafedra profilakticheskoĭ i neotlozhnoĭ kardiologii FPPOV, Moskva

Kopylov F.Iu.

Pervyĭ MGMU im. I.M. Sechenova, kafedra profilakticheskoĭ i neotlozhnoĭ kardiologii FPPOV, Moskva

Scopus AuthorID: 6507736224
ORCID: 0000-0001-5124-6383

List of references:

McCarthy B., Wong J., Selker H. Detecting acute ischemia in the emergency department. J Gen Int Med 1990; 5: 365-373.
Rouan G., Lee T., Cook E. Clinical characteristics and outcome of acute myocardial infarction in patients with normal or nonspecific electrocardiograms. Am J Cardiol 1989; 64: 1087-1092.
Pozen M., D'Agostino R., Selker H. A predictive instrument to improve CCU admission practices in acute ischemic heart disease. A prospective multicenter clinical trial. N Engl J Med 1984; 310: 1279-1292.
Wu A., Apple F., Gibler B. et al. National Academy of Clinical Biochemistry standarts of laboratory practice: recomendations for the use of cardiac marker in coronary artery disease. Clin Chem 1999; 45: 1104-1121.
Glatz J.F., van der Vusse G.J. Cellular fatty acid-binding proteins: their function and physiological significance. Prog Lipid Res 1996; 35: 243-282.
Glatz J.F., van Bilsen M. , Paulussen R.J. et al. Release of fatty acid-binding protein from isolated rat heart subjected to ischemia and reperfusion or to the calcium paradox. Biochim Biophys Acta 1988; 961: 1: 148-152.
Glatz J.F., Storch J. Unraveling the significance of cellular fatty acid-binding proteins. Curr Opin Lipidol 2001; 12: 267-274.
Zschiesche W., K eine A.H., Spitzer E. et al. Histochemical localization of heart-type fatty acid-binding protein in human and murine tissues. Histochem Cell Biol 1995; 103: 147-156.
Maatman R.G., van de Westerlo E.M., van Kuppevelt T.H., Veerkamp J.H. Molecular identification of the liver- and the heart-type fatty acid-binding proteins in human and rat kidney. Use of the reverse transcriptase polymerase chain reaction. Biochem J 1992; 288: 285-290.
Pelsers M.M., Hanhoff T., Van der Voort D. et al. Brain- and heart-type fatty acid-binding proteins in the brain: tissue distribution and clinical utility. Clin Chem 2004; 50: 1568-1575.
Glatz J., Kleine A.H., Van Nieuwenhoven F.A. et al. Fatty-acid-binding protein as a plasma marker for the estimation of myocardial infarct size in humans. Eur Heart J 1994; 71: 135-140.
Yoshimoto K., Tanaka T., Somiya K. et al. Human heart-type cytoplasmic fatty acid-binding protein as an indicator of acute myocardial infarction. Heart Vessels 1995; 10: 304-305.
Pelsers M.M., Chapelle J.P., Knapen M. et al. Influence of age and sex and day-to-day and within-day biological variation on plasma concentrations of fatty acid-binding protein and myoglobin in healthy subjects. Clin Chem 1999; 45: 441-443.
Hamm C.W., Bassand J.P., Agewall S. et al. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation of the European Society of Cardiology. Eur Heart J 2011; 32: 23: 2999-3054.
Tanaka T., Hirota Y., Sohmiya K. et al. Serum and urinary human heart fatty acid-binding protein in acute myocardial infarction. Clin Biochem 1991; 24: 195-201.
Kleine A.H., Glatz J.F.C., Van Nieuwenhoven F.A., Van der Vusse G.J. Release of heart fatty acid-binding protein after acute myocardial infarction in man. Mol Cell Biochem 1992; 116: 155-162.
Knowlton A.A., Apstein C.S., Saouf R., Brecher P. Leakage of heart fatty acid binding protein with ischemia and reperfusion in the rat. J Mol Cell Cardiol 1989; 21: 577-583.
Sohmiya K., Tanaka T., Tsuji R. et al. Plasma and urinary heart-type cytoplasmic fatty acid-binding protein in coronary occlusion and reperfusion induced myocardial injury model. J Mol Cell Cardiol 1993; 25: 1413-1426.
Vork M.M., Glatz J.F., Surtel D.A., Van der Vusse G.J. Release of fatty acid binding protein and lactate dehydrogenase from isolated rat heart during normoxia, low-flow ischemia, and reperfusion. Can J Physiol Pharmacol 1993; 71: 952-958.
Trifonov I.R. Biokhimicheskie markery nekroza miokarda. Chast' I. Obshchaya kharakteristika biomarkerov. Ikh primenenie dlya diagnostiki infarkta miokarda: obzor sovremennykh rekomendatsii. Kardiologiya 2001; 11: 93-98.
Wu A., Ghani F., Graff L. et al. Role of heart fatty acid-binding protein in early detection of acute myocardial infarction. Clin Chem 2000; 46: 718-719.
Ishii J., Wang J.H., Naruse H. et al. Serum concentrations of myoglobin vs human heart-type cytoplasmic fatty acid-binding protein in early detection of acute myocardial infarction. Clin Chem 1997; 43: 1372-1378.
Kapetanios K., Pitsavos C., Vassiliadou K. et al. Heart fatty acid binding protein: the advent of a unique marker for the early detection of acute myocardial infarction patients. Eur Heart J 2001; 22: Suppl: 608.
Ishii J., Nomura M., Naruse H. et al. Heart-type fatty acid-binding protein is more useful than cardiac troponin T and CK-MD isoforms for risk stratification in patients with acute coronary syndrome within 3 hrs after onset of chest pain. Circulation 2001; 37: 648A.
Kaptein W., Cheng S., Glatz J. et al. Early detection of acute myocardial infarction with the new marker fatty acid-binding protein: kinetic release and diagnostic value. Eur Heart J 2000; 21: Suppl: 524.
Okamoto F., Sohmiya K., Ohkaru Y. et al. Human heart-type cytoplasmic fatty acid-binding protein (H-FABP) for the diagnosis of acute myocardial infarction. Clinical evaluation of H-FABP in comparison with myoglobin and creatine kinase isoenzyme MB. Clin Chem Lab Med 2000; 3: 231-238.
Glatz J.F., van der Vusse G.J., Simoons M.L., Kragten J.A. et al. Fatty acid-binding protein and the early detection of acute myocardial infarction. Clin Chim Acta 1998;. 272: 87-92.
McCann C.J., Glover V.M., Menown I.B. et al. Novel Biomarkers in Early Diagnosis of Acute Myocardial Infarction Compared With Cardiac Troponin T. Eur Heart J 2008; 29: 23: 2843-2850.
Colli A., Josa M., Pomar J. et al. Heart Fatty Acid Binding Protein in the Diagnosis of Myocardial Infarction: Where Do We Stand Today? Cardiology 2007; 108: 4-10.
Nayashida N., Chihara S., Tayama E. et al. Influence of renal function on serum and urinary heart fatty acid-binding protein levels. J Cardiovasc Surg (Torino) 2001; 42: 735-740.
Bruins M.H., Reitsma J.B., Rutten F.H. et al. Heart-type fatty acid-binding protein in the early diagnosis of acute myocardial infarction: a systematic review and meta-analysis. Heart 2010; 96: 24: 1957-1963.
Ishii J., Ozaki Y., Lu J. et al. Prognostic value of serum concentration of heart-type fatty acid-binding protein relative to cardiac troponin T on admission in the early hours of acute coronary syndrome. Clin Chem 2005; 51: 1397-1404.
Erlikh A.D., Katrukha A.G., Trifonov I.R. i dr. Ostryi koronarnyi sindrom bez pod''ema segmenta ST na EKG. Prognosticheskoe znachenie serdechnogo belka, svyazyvayushchego zhirnye kisloty. Rezul'taty 12-mesyachnogo nablyudeniya. Kardiologiya 2005; 45: 5: 13-21.
O'Donoghue M., de Lemos J.A., Morrow D.A. et al. Prognostic utility of heart-type fatty acid binding protein in patients with acute coronary syndromes. Circulation 2006; 114: 550-557.
McCann C.J., Glover B.M., Menown I.B. et al. Prognostic value of a multimarker approach for patients presenting to hospital with acute chest pain. Am J Cardiol 2009; 103: 22-28.
Nakata T., Hashimoto A., Hase M. et al. Human heart-type fatty acid-binding protein as an early diagnostic and prognostic marker in acute coronary syndrome. Cardiology 2003; 99: 96-104.
Suzuki M., Hori S., Noma S., Kobayashi K. Prognostic value of a qualitative test for heart-type fatty acid-binding protein in patients with acute coronary syndrome. Int Heart J 2005; 46: 601-606.
Ishii J., Ozaki Y., Lu J. et al. Prognostic value of serum concentration of heart-type fatty acid-binding protein relative to cardia

Close metadata